Litcius/Paper detail

Anti-osteosarcoma effect of hydroxyapatite nanoparticles both <i>in vitro</i> and <i>in vivo</i> by downregulating the FAK/PI3K/Akt signaling pathway

Renxian Wang, Weifeng Liu, Qian Wang, Guangping Li, Ben Wan, Yuyang Sun, Xiaohui Niu, Dafu Chen, Wei Tian

2020Biomaterials Science39 citationsDOI

Abstract

Correction for 'Anti-osteosarcoma effect of hydroxyapatite nanoparticles both in vitro and in vivo by downregulating the FAK/PI3K/Akt signaling pathway' by Renxian Wang et al., Biomater. Sci., 2020, 8, 4426-4437, DOI: 10.1039/D0BM00898B.

Topics & Concepts

PI3K/AKT/mTOR pathwayIn vivoIn vitroProtein kinase BOsteosarcomaChemistrySchematicSignal transductionCell biologyCancer researchPhosphorylationBiologyBiochemistryGeneticsEngineeringElectronic engineeringProtease and Inhibitor MechanismsCell Adhesion Molecules ResearchPeptidase Inhibition and Analysis
Anti-osteosarcoma effect of hydroxyapatite nanoparticles both <i>in vitro</i> and <i>in vivo</i> by downregulating the FAK/PI3K/Akt signaling pathway | Litcius